Hemato Oncology Testing Market Research Report
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Hemato Oncology Testing Market, By Cancer Type
7.1. Hemato Oncology Testing Market, By Cancer Type, 2020-2030
7.1.1. Leukemia
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Lymphoma
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Myeloproliferative Neoplasms
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Other Cancers
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Hemato Oncology Testing Market, By Product Type
8.1. Hemato Oncology Testing Market, By Product Type, 2020-2030
8.1.1. Assay Kits and Reagents
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Hemato Oncology Testing Market, By Technology Type
9.1. Hemato Oncology Testing Market, By Technology Type, 2020-2030
9.1.1. PCR
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. IHC
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. NGS
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Cytogenetics
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Other Technologies
9.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Hemato Oncology Testing Market, By End-Use Type
10.1. Hemato Oncology Testing Market, By End-Use Type, 2020-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Academic & Research Institutes
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Hemato Oncology Testing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.1.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.1.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.1.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.2.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.2.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.2.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.3.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.3.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.3.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.4.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.4.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.4.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.5.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.5.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.5.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Cancer Type (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Product Type (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Technology Type Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, By End-Use Type (2016-2030)
Chapter 12. Company Profiles
12.1. F. Hoffman-La Roche Ltd
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. EntroGen, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Qiagen N.V.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cepheid
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Thermo Fisher Scientific, Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-Rad Laboratories, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Illumina, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers